Darius Mason, Pharm.D., BCPS



  • Pharm.D., University of Tennessee Health Science Center, Memphis, TN
  • Internal Medicine Residency, Methodist Le Bonheur Healthcare, Memphis, TN
  • Nephrology Pharmacotherapy Fellowship, University of Illinois at Chicago, Chicago, IL 

Courses Taught at ACPHS

  • Pharmacotherapy – General Nephrology, Mineral and Bone Disease, & Electrolyte Disturbances
  • Principles of Pharmacogenomics
  • Advanced Pharmacy Practice Experience –Nephrology Ambulatory Care – Outpatient Hemodialysis


Adjunct Assistant Professor
Department of Medicine – Division of Nephrology and Hypertension
Albany Medical College
Albany, NY 12208

Research Interests

  • Hypertension pharmacotherapy in chronic kidney disease (CKD)
  • Evaluation of vascular calcification biomarkers in kidney disease
  • Vitamin D and phosphorus metabolism (mineral and bone disease) in healthy & CKD
  • Evaluation of noninvasive biomarkers of neurological insult in kidney disease

Funded Clinical Studies

  • “Sustainability of serum [25OHD] levels, inflammatory reduction, and endothelial dysfunction after repletion with ergocalciferol in CKD Stage 5D.” NCT01312441
  • “A Randomized Study on the Effects of Sevelamer Carbonate versus Calcium Acetate on Biomarkers of Vascular Calcification, Inflammation, and Endothelial Dysfunction in Chronic Kidney Disease Stages 3 and 4.” NCT01277497

Selected Publications

Associate Professor
Department of Pharmacy Practice